Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2

NCT06607367 is registered in ClinicalTrials.gov with Melbourne Health as lead sponsor.

NCT NCT06607367
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06607367 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2
Lead sponsor
Melbourne Health
Phase
Phase 1/2
Overall status
Not yet recruiting
Start date
October 30, 2024
Completion date
October 30, 2026
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aplastic anemia idiopathic, poor graft function